Literature DB >> 20573832

Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles.

Michael L Grantham1, Shaun M Stewart, Erin N Lalime, Andrew Pekosz.   

Abstract

The cytoplasmic tail of the influenza A virus M2 protein is required for the production of infectious virions. In this study, critical residues in the M2 cytoplasmic tail were identified by single-alanine scanning mutagenesis. The tyrosine residue at position 76, which is conserved in >99% of influenza virus strains sequenced to date, was identified as being critical for the formation of infectious virus particles using both reverse genetics and a protein trans-complementation assay. Recombinant viruses encoding M2 with the Y76A mutation demonstrated replication defects in MDCK cells as well as in primary differentiated airway epithelial cell cultures, defects in the formation of filamentous virus particles, and reduced packaging of nucleoprotein into virus particles. These defects could all be overcome by a mutation of serine to tyrosine at position 71 of the M2 cytoplasmic tail, which emerged after blind passage of viruses containing the Y76A mutation. These data confirm and extend our understanding of the significance of the M2 protein for infectious virus particle assembly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573832      PMCID: PMC2918991          DOI: 10.1128/JVI.00853-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus.

Authors:  K Tobler; M L Kelly; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

3.  Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.

Authors:  J Zhang; A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

5.  Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells.

Authors:  O P Zhirnov; T E Konakova; W Garten; H Klenk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.

Authors:  Makoto Takeda; Andrew Pekosz; Kevin Shuck; Lawrence H Pinto; Robert A Lamb
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Reverse genetics studies on the filamentous morphology of influenza A virus.

Authors:  Svetlana V Bourmakina; Adolfo García-Sastre
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

8.  Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes.

Authors:  Jorgen A Mould; Reay G Paterson; Makoto Takeda; Yuki Ohigashi; Padma Venkataraman; Robert A Lamb; Lawrence H Pinto
Journal:  Dev Cell       Date:  2003-07       Impact factor: 12.270

9.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.

Authors:  S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  The molecular basis of the specific anti-influenza action of amantadine.

Authors:  A J Hay; A J Wolstenholme; J J Skehel; M H Smith
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  22 in total

Review 1.  Influenza virus assembly and budding.

Authors:  Jeremy S Rossman; Robert A Lamb
Journal:  Virology       Date:  2011-01-14       Impact factor: 3.616

2.  Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection.

Authors:  Huailiang Ma; François Kien; Maxime Manière; Yang Zhang; Nadège Lagarde; Kong San Tse; Leo Lit Man Poon; Béatrice Nal
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

3.  Mutations in the membrane-proximal region of the influenza A virus M2 protein cytoplasmic tail have modest effects on virus replication.

Authors:  Shaun M Stewart; Andrew Pekosz
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  A Budding-Defective M2 Mutant Exhibits Reduced Membrane Interaction, Insensitivity to Cholesterol, and Perturbed Interdomain Coupling.

Authors:  Alice L Herneisen; Indra D Sahu; Robert M McCarrick; Jimmy B Feix; Gary A Lorigan; Kathleen P Howard
Journal:  Biochemistry       Date:  2017-11-07       Impact factor: 3.162

5.  Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication.

Authors:  Nicholas Wohlgemuth; Andrew P Lane; Andrew Pekosz
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

6.  Mutations in the Influenza A Virus M1 Protein Enhance Virus Budding To Complement Lethal Mutations in the M2 Cytoplasmic Tail.

Authors:  Hsuan Liu; Michael L Grantham; Andrew Pekosz
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

7.  Autophagy Promotes Replication of Influenza A Virus In Vitro.

Authors:  Ruifang Wang; Yinxing Zhu; Jiachang Zhao; Chenwei Ren; Peng Li; Huanchun Chen; Meilin Jin; Hongbo Zhou
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

8.  Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells.

Authors:  William A Fischer; Landon S King; Andrew P Lane; Andrew Pekosz
Journal:  Vaccine       Date:  2015-07-18       Impact factor: 3.641

9.  Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.

Authors:  Min-Chul Kim; Yu-Na Lee; Hye Suk Hwang; Young-Tae Lee; Eun-Ju Ko; Yu-Jin Jung; Min Kyoung Cho; Yu-Jin Kim; Jong Seok Lee; Suk-Hoon Ha; Sang-Moo Kang
Journal:  Vaccine       Date:  2014-08-27       Impact factor: 3.641

10.  The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.

Authors:  Nicholas Wohlgemuth; Yang Ye; Katherine J Fenstermacher; Hsuan Liu; Andrew P Lane; Andrew Pekosz
Journal:  Vaccine       Date:  2017-10-25       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.